Endologix is headquartered in Irvine, US

Endologix has offices in Irvine and Rosmalen

Irvine, US (HQ)

2 Musick

Rosmalen, NL

40 Burgemeester Burgerslaan

## Revenue (2016) | $192.9 m |

## Revenue growth (2015-16), % | 26% |

## Gross profit | $123.8 m |

## Gross profit margin (2016), % | 64% |

## Net income (2016) | ($154.7 m) |

## Market capitalization (28-Apr-2017) | $621.1 m |

## Closing share price (28-Apr-2017) | $7.5 |

## Cash (31-Dec-2016) | $26.1 m |

Endologix's current market capitalization is $621.1 m.

Endologix's revenue was reported to be $192.9 m in FY, 2016 which is a **26% increase** from the previous period.

FY, 2013^{} | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} | |
---|---|---|---|---|

## Revenue | $132.3 m | $147.6 m | $153.6 m | $192.9 m |

## Revenue growth, % | 12% | 4% | 26% | |

## Cost of goods sold | $41.8 m | $51.8 m | $69.1 m | |

## Gross profit | $99.5 m | $105.8 m | $101.8 m | $123.8 m |

## Gross profit Margin, % | 75% | 72% | 66% | 64% |

## Operating expense total | $109.9 m | $134.9 m | $154.7 m | $218.9 m |

## EBIT | ($10.4 m) | ($29.1 m) | ($52.9 m) | ($95.1 m) |

## EBIT margin, % | (8%) | (20%) | (34%) | (49%) |

## Interest expense | $321 k | $5.7 m | $7.5 m | $15.8 m |

## Interest income | $50 k | $245 k | $175 k | $228 k |

## Income tax expense | $10 k | $62 k | $9.3 m | ($498 k) |

## Net Income | ($16.1 m) | ($32.4 m) | ($50.4 m) | ($154.7 m) |

FY, 2013^{} | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} | |
---|---|---|---|---|

## Cash | $95.2 m | $26.8 m | $124.6 m | $26.1 m |

## Accounts Receivable | $310 k | $498 k | $375 k | $1.8 m |

## Inventories | $19.6 m | $31.3 m | $27.9 m | $41.2 m |

## Current Assets | $173.6 m | $147.8 m | $237.5 m | $129.8 m |

## PP&E | $7.3 m | $25.7 m | $23.4 m | $23.3 m |

## Goodwill | $29.1 m | $28.9 m | $28.7 m | $120.7 m |

## Total Assets | $256.2 m | $248.2 m | $335.8 m | $359.7 m |

## Accounts Payable | $6.3 m | $11 m | $17.5 m | $13.2 m |

## Current Liabilities | $67.3 m | $29.6 m | $50.9 m | $44.9 m |

## Additional Paid-in Capital | $321.8 m | $372.6 m | $404.5 m | $567.8 m |

## Retained Earnings | ($216.1 m) | ($248.5 m) | ($298.9 m) | ($453.6 m) |

## Total Equity | $103.3 m | $112.8 m | ||

## Financial Leverage | 3.3 x | 3.2 x |

FY, 2013^{} | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} | |
---|---|---|---|---|

## Net Income | ($32.4 m) | ($50.4 m) | ($154.7 m) | |

## Depreciation and Amortization | $3.3 m | $5.9 m | $9.1 m | |

## Accounts Receivable | ||||

## Inventories | ($12 m) | $3.5 m | $3.5 m | |

## Accounts Payable | $2.7 m | $8.3 m | ($5.2 m) | |

## Cash From Operating Activities | $50 m | ($26.3 m) | ($31.1 m) | ($74.8 m) |

## Purchases of PP&E | ($13.5 m) | ($4.2 m) | ($2.8 m) | |

## Cash From Investing Activities | ($43.3 m) | $2.9 m | ($28.5 m) | |

## Cash From Financing Activities | $2.1 m | $126.7 m | $5.3 m | |

## Interest Paid | $2 m | $2 m | $6.3 m | |

## Income Taxes Paid | $258 k | $124 k | $208 k |